Applying a lean delivery approach to the design and construction of new facilities can reduce waste, lower costs and improve speed to market.
Read More
How to incorporate highly potent drug products into your facility
There are many benefits to adding highly potent drug products to your portfolio, including increasing demand and generating potentially higher profit margins. Making the decision to incorporate highly potent drug products into your manufacturing facility can be a challenging process.
Read More
How biopharma facilities can use ice in a glycol chiller system
Ice storage, coupled with a glycol chiller, can provide benefits that other options can’t.
Read More
Continuous OSD manufacturing—a technology update
Continuous oral solid dosage manufacturing is a transformational processing platform that is here today and is here to stay. Although the industry is working on harmonization and some level of standardization of the platforms, continuous manufacturing is not a one-size-fits all offering.
Read More
When to close your pharmaceutical process
Too often, the term “closed process” is thrown around without an understanding of the salient issues. Pharmaceutical process closure can certainly provide many benefits, but there are various impacts and requirements depending on the ultimate goal and the specific process you are trying to close.
Read More
Cybersecurity considerations for pharmaceutical companies
Who would want to hack a programmable logic controller? Is cybersecurity really that important for pharma companies?
Read More
Continuous OSD manufacturing and patient impact
FDA approved oral solid dosage (OSD) products are improving, changing and enhancing lives, via the use of a continuous manufacturing platform.
Read More
Passing through the barrier
Over the past decade, aseptic filling isolators have improved patient safety by use of barriers to isolate the point of filling from personnel. This industry-wide movement creates opportunities to further increase patient safety by minimizing viable and nonviable risks to the aseptic fill.
Read More
How to choose a contract manufacturing organization
The age-old debate of whether to outsource production to a contract manufacturing organization (CMO) remains for mature, emerging and virtual biopharmaceutical companies.
Read More
Building a thoughtful manufacturing supply chain
In the past 5 years, the biopharmaceutical industry has seen unprecedented change. Precipitated by the need to support a global client base with products that are more targeted, efficacious and cost-effective, the challenge to have a robust manufacturing supply chain is more crucial than ever to a company’s survival.
Read More